NR4A2 and Parkinson disease: The pattern of differences between HS and PD patients was the same as in study #1 (Additional file 2: Figure S11), with lower levels of TBX21, STAT3, STAT4, and NR4A2, and higher levels of STAT6, GATA3, and FOXP3 in cells from PD patients.